查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413346

稀有生物标记检体采集和稳定市场：按产品类型、采集类型、应用和最终用途 - 2024-2030 年全球预测

Rare Biomarkers Specimen Collection & Stabilization Market by Product Type, Collection Type, Application, End Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

稀有生物标记检体采集和稳定市场规模预计到2023年为299.4亿美元，2024年达到322.1亿美元，2030年达到498.3亿美元，复合年增长率为7.54%。

稀有生物标记检体采集和稳定的全球市场

主要市场统计
基准年[2023] 299.4亿美元
预测年份 [2024] 322.1亿美元
预测年份 [2030] 498.3亿美元
复合年增长率（%） 7.54%
稀有生物标记标本采集及稳定市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵对于评估稀有生物标记检体收集和稳定市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对稀有检体分析物收集和稳定市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-稀有生物标记检体采集和稳定市场的市场规模和预测是多少？

2-在稀有生物标记检体采集和稳定市场的预测期内，需要考虑投资的产品、细分市场、应用和领域有哪些？

3-稀有生物标记检体采集和稳定市场的技术趋势和法律规范是什么？

4-稀有生物标记检体采集和稳定市场主要供应商的市场占有率是多少？

5-进入稀有生物标记检体采集和稳定市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加非侵入性疾病治疗的选择
      • 个人化医疗需求不断成长
      • 越来越多的研究揭示了循环生物标记的作用
    • 抑制因素
      • 严格的行业法规
    • 机会
      • 新的检测创新，例如液体活体组织切片检测
      • 共同努力开拓市场
    • 任务
      • 有限兑换场景
      • 表征复杂性和低效的分离方案
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章稀有生物标记检体采集与稳定市场：依产品类型

  • 循环游离DNA
  • 循环性肿瘤细胞
  • 胞外体或细胞外囊泡

第七章稀有生物标记检体采集与稳定市场（依采集类型）

  • 采血管及采血管系统
  • 分离套件和试剂

第八章稀有生物标记检体采集与稳定市场：依应用分类

  • 心血管疾病
  • NIPT
  • 肿瘤学
  • 药物基因组学
  • 大规模筛检
  • 转录组学
  • 移植排斥反应

第九章稀有生物标记检体采集与稳定市场：依最终用途分类

  • 医院
  • 周产期门诊
  • 医生实验室
  • 私人或商业实验室
  • 公共卫生研究所
  • 调查机构

第十章美洲稀有生物标记检体采集与稳定市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区稀有生物标记检体采集及稳定市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的稀有生物标记检体采集和稳定市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • ABL, Inc.
    • ACM Global Laboratories
    • Almac Group
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • BioAgilytix Labs, LLC
    • bioMerieux, Inc.
    • Charles River Laboratories International, Inc.
    • IQVIA Inc.
    • Labcorp Drug Development
    • NorthEast BioAnalytical Laboratories LLC
    • PerkinElmer Inc.
    • SGS Societe Generale de Surveillance SA
    • Svar Life Science AB
    • Synexa Life Sciences BV
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-B812DD579A30

[182 Pages Report] The Rare Biomarkers Specimen Collection & Stabilization Market size was estimated at USD 29.94 billion in 2023 and expected to reach USD 32.21 billion in 2024, at a CAGR 7.54% to reach USD 49.83 billion by 2030.

Global Rare Biomarkers Specimen Collection & Stabilization Market

KEY MARKET STATISTICS
Base Year [2023] USD 29.94 billion
Estimated Year [2024] USD 32.21 billion
Forecast Year [2030] USD 49.83 billion
CAGR (%) 7.54%
Rare Biomarkers Specimen Collection & Stabilization Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rare Biomarkers Specimen Collection & Stabilization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rare Biomarkers Specimen Collection & Stabilization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rare Biomarkers Specimen Collection & Stabilization Market, highlighting leading vendors and their innovative profiles. These include ABL, Inc., ACM Global Laboratories, Almac Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, bioMerieux, Inc., Charles River Laboratories International, Inc., IQVIA Inc., Labcorp Drug Development, NorthEast BioAnalytical Laboratories LLC, PerkinElmer Inc., SGS Societe Generale de Surveillance SA, Svar Life Science AB, and Synexa Life Sciences BV.

Market Segmentation & Coverage

This research report categorizes the Rare Biomarkers Specimen Collection & Stabilization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Circulating Cell Free DNA
    • Circulating Tumor Cells
    • Exosomes or Extracellular Vesicles
  • Collection Type
    • Blood Collection Tubes & Systems
    • Isolation Kits & Reagents
  • Application
    • Cardiovascular Diseases
    • NIPT
    • Oncology
    • Pharmacogenomics
    • Population Screening
    • Transcriptomics
    • Transplant Rejection
  • End Use
    • Hospitals
    • Perinatal Clinics
    • Physician Labs
    • Private or Commercial Labs
    • Public Health Labs
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Rare Biomarkers Specimen Collection & Stabilization Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rare Biomarkers Specimen Collection & Stabilization Market?

3. What are the technology trends and regulatory frameworks in the Rare Biomarkers Specimen Collection & Stabilization Market?

4. What is the market share of the leading vendors in the Rare Biomarkers Specimen Collection & Stabilization Market?

5. Which modes and strategic moves are suitable for entering the Rare Biomarkers Specimen Collection & Stabilization Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Rare Biomarkers Specimen Collection & Stabilization Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising preference of a non-invasive mode of disease treatment
      • 5.1.1.2. Increasing demand for personalized medicine
      • 5.1.1.3. Growth in number of research studies to depict the role of circulating biomarkers
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations in the industry
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation of novel assays such as liquid biopsy assays
      • 5.1.3.2. Collaborative initiatives for market developments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited reimbursement scenario
      • 5.1.4.2. Complexities in characterization and ineffective separation protocols
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Rare Biomarkers Specimen Collection & Stabilization Market, by Product Type

  • 6.1. Introduction
  • 6.2. Circulating Cell Free DNA
  • 6.3. Circulating Tumor Cells
  • 6.4. Exosomes or Extracellular Vesicles

7. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Type

  • 7.1. Introduction
  • 7.2. Blood Collection Tubes & Systems
  • 7.3. Isolation Kits & Reagents

8. Rare Biomarkers Specimen Collection & Stabilization Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. NIPT
  • 8.4. Oncology
  • 8.5. Pharmacogenomics
  • 8.6. Population Screening
  • 8.7. Transcriptomics
  • 8.8. Transplant Rejection

9. Rare Biomarkers Specimen Collection & Stabilization Market, by End Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Perinatal Clinics
  • 9.4. Physician Labs
  • 9.5. Private or Commercial Labs
  • 9.6. Public Health Labs
  • 9.7. Research Institutes

10. Americas Rare Biomarkers Specimen Collection & Stabilization Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Rare Biomarkers Specimen Collection & Stabilization Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Rare Biomarkers Specimen Collection & Stabilization Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. ABL, Inc.
    • 14.1.2. ACM Global Laboratories
    • 14.1.3. Almac Group
    • 14.1.4. Becton, Dickinson and Company
    • 14.1.5. Bio-Rad Laboratories, Inc.
    • 14.1.6. BioAgilytix Labs, LLC
    • 14.1.7. bioMerieux, Inc.
    • 14.1.8. Charles River Laboratories International, Inc.
    • 14.1.9. IQVIA Inc.
    • 14.1.10. Labcorp Drug Development
    • 14.1.11. NorthEast BioAnalytical Laboratories LLC
    • 14.1.12. PerkinElmer Inc.
    • 14.1.13. SGS Societe Generale de Surveillance SA
    • 14.1.14. Svar Life Science AB
    • 14.1.15. Synexa Life Sciences BV
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET DYNAMICS
  • FIGURE 7. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 8. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 10. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 14. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING CELL FREE DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES OR EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NIPT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PERINATAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHYSICIAN LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRIVATE OR COMMERCIAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 195. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 196. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET LICENSE & PRICING